NEOPLASMA
Article List
Volume 66, 2019, No. 5
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- Guha, A. - Musil, Z. - Vicha, A. - Zelinka, T. - Pacak, K. - Astl, J. - Chovanec, M.: A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas. (p. 671)
- Tang, D. - Wu, Q. - Yuan, Z. - Xu, J. - Zhang, H. - Jin, Z. - Zhang, Q. - Xu, M. - Wang, Z. - Dai, Z. - Fang, H. - Li, Z. - Lin, C. - Shi, C. - Xu, M. - Sun, X. - Wang, D.: Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis. (p. 681)
- Zhang, B. - Cao, K. - Liu, Z. - Shan, W. - Wen, Q. - Wang, R.: Receptor interacting protein kinase 3 promotes cisplatin-induced necroptosis in apoptosis-resistant HepG2/DDP cells. (p. 694)
- Zhang, X. - Jin, K. - Luo, J. - Liu, B. - Xie, L.: MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1. (p. 704)
- Zhang, H. - Zhang, D. - Ju, T. - Zhou, J.: The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis. (p. 717)
- Shi, G. - Lv, C. - Yang, Z. - Qin, T. - Sun, L. - Pan, P. - Wang, D.: TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway. (p. 727)
- Liu, L. - Wu, S. - Zhu, X. - Xu, R. - Ai, K. - Zhang, L. - Zhao, X.: Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. (p. 736)
- Tao, L. - Wu, Y. - Zhang, S.: MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4. (p. 746)
- Shi, S. - Zhang, Z.: Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway. (p. 756)
- Li, S. - Li, J.: Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation. (p. 766)
- Mai, L. - Luo, M. - Wu, J. - Yang, J. - Hong, L.: The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells. (p. 776)
- Lu, J. - Zhao, J. - Jia, C. - Zhou, L. - Cai, Y. - Ni, J. - Ma, J. - Zheng, M. - Lu, A.: FPR2 enhances colorectal cancer progression by promoting EMT process. (p. 785)
- Song, T. - Liu, J. - Yang, J.: NKAP plays an oncogenic function partly through AKT signaling pathway in hepatocellular carcinoma. (p. 792)
- Bar, J. - Grelewski, P. - Deszcz, I. - Noga, L. - Hirnle, L. - Lis-Nawara, A.: Association between p53 protein phosphorylated at serine 20 expression and ovarian carcinoma stem cells phenotype: correlation with clinicopathological parameters of ovarian cancer. (p. 801)
- Li, J. - Zhang, X. - Zhang, Y. - Zheng, L. - Liu, Y.: The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in triple-negative breast cancer. (p. 810)
- Fabri, O. - Horakova, J. - Bodova, I. - Svec, P. - Laluhova Striezencova, Z. - Bubanska, E. - Cermak, M. - Galisova, V. - Skalicka, K. - Vaska, A. - Doczyova, D. - Panikova, A. - Sykora, T. - Adamcakova, J. - Kolenova, A.: Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approaches. (p. 818)
- Yi, S. - Liu, P. - Chen, B. - Ou-Yang, L. - Xiong, W. - Su, J.: Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma. (p. 825)
- Jirkovska, M. - Novak, T. - Malinova, B. - Lohynska, R.: Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma. (p. 830)
- Xu, L. - Xiong, H. - Shi, W. - Zhou, F. - Zhang, M. - Hu, G. - Mei, J. - Luo, S. - Chen, L.: Differential expression of sonic hedgehog in lung adenocarcinoma and lung squamous cell carcinoma. (p. 839)
- Huang, L. - Liu, T. - Ji, H. - Yang, S. - Sui, J. - Yang, W. - Liang, G. - Zhang, X.: Expression pattern of estrogen receptor β and its correlation with multidrug resistance in non-small cell lung cancer. (p. 847)